Clinical Trial Update: Resistance to Lamivudine in HBV Egyptian Patients

View source ↗

Summary

A clinical trial conducted by Ain Shams University examining lamivudine resistance in Egyptian patients with chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Epivir-HBV (lamivudine)
• Lamivudine (lamivudine)

Snippet

Sponsor: Ain Shams University | Conditions: Chronic Hepatitis B Virus Treatment | Status: COMPLETED